Smith & Nephew stock receives consensus "hold" rating: 4 takeaways

Spinal Tech

MarketBeat reports that Smith & Nephew stock has been given a consensus rating of "hold" by the 16 firms currently covering the firm, according to a Dakota Financial News report.

Here are four takeaways:

 

1. The average 12-month price target for the stock among brokerages is $18.76.

 

2. The company's market capitalization is $153,981.

 

3. The company's 50 day moving average is $17.66 and its 200-day moving average is $17.45.

 

4. Smith & Nephew has a one-year low of $13.46 and a one-year high of $18.58.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers